These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 7662220

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure.
    Reaven GM, Clinkingbeard C, Jeppesen J, Maheux P, Pei D, Foote J, Hollenbeck CB, Chen YD.
    Am J Hypertens; 1995 May; 8(5 Pt 1):461-6. PubMed ID: 7662221
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS, Hatzitolios AI, Adamidou A, Giannopoulos S, Raikos N, Parharidis G, Milionis HJ.
    Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
    [Abstract] [Full Text] [Related]

  • 6. [Lisinopril in the monotherapy of patients with essential hypertension: the effect of therapy on glucose and lipid metabolism].
    Gajdos M, Spustová V, Dzúrik R.
    Cas Lek Cesk; 1993 Dec 06; 132(23):709-14. PubMed ID: 8293440
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 06; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group.
    Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936
    [Abstract] [Full Text] [Related]

  • 10. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters].
    Caballero Oliver A, Stiefel García-Junco P, García-Donas López MA, Villar Ortiz J, Carneado de la Fuente J.
    Med Clin (Barc); 1995 Dec 08; 105(20):768-73. PubMed ID: 8558976
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension.
    Kedzierska K, Bober J, Ciechanowski K, Gołembiewska E, Kwiatkowska E, Noceń I, Dołegowska B, Dutkiewicz G, Chlubek D.
    Biol Trace Elem Res; 2005 Oct 08; 107(1):21-32. PubMed ID: 16170219
    [Abstract] [Full Text] [Related]

  • 13. Lisinopril administration improves insulin action in aged patients with hypertension.
    Paolisso G, Balbi V, Gambardella A, Varricchio G, Tortoriello R, Saccomanno F, Amato L, Varricchio M.
    J Hum Hypertens; 1995 Jul 08; 9(7):541-6. PubMed ID: 7562882
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 08; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 16. Some metabolic aspects of essential hypertension and its treatment.
    Santoro D, Galvan AQ, Natali A, Ferrannini E.
    Am J Med; 1993 Apr 23; 94(4A):32S-39S. PubMed ID: 8488854
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 19. Interactions between insulin and sodium homeostasis in essential hypertension.
    Semplicini A, Ceolotto G, Massimino M, Valle R, Serena L, De Toni R, Pessina AC, Dal Palù C.
    Am J Med Sci; 1994 Feb 25; 307 Suppl 1():S43-6. PubMed ID: 8141164
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.